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To determine the usefulness of chondroitin sulfate iron colloid (CSIC)-enhanced
magnetic resonance imaging (MRI) in evaluation of the histologic grade of hepato-
cellular carcinoma (HCC), we performed a comparative study with computed tomog-
raphy during arterial portography (CTAP) and CT arteriography.  Twenty-one surgi-
cally resected HCCs 3 cm or less in diameter were examined.  There were five well-
differentiated, six well- to moderately-differentiated and ten moderately- or poorly-
differentiated HCCs.  T2-weighted spin echo images (repetition time:  2,000 ms, echo
time:  90 ms) were taken before and after intravenous injection of 23.6 µmolFe/kg of
CSIC.  The differences between precontrast and postcontrast contrast-to-noise ratios
(enhancement index) was correlated with the findings of CTAP, CT arteriography and
histological examination.  The enhancement index increased with statistical signif-
icance as the intranodular arterial perfusion increased (P < 0.01), and as the intra-
nodular portal perfusion decreased (P < 0.01).  Though the enhancement index tended
to increase as the grade of malignancy increased, no statistical significance was found.
CSIC-enhanced MRI allowed a noninvasive evaluation of the intranodular reticulo-
endothelial function.  We consider this procedure as a supplementary method for
evaluation of the histologic grade of HCC prior to performing invasive procedures
such as angiography and biopsy.
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We have used chondroitin sulfate iron colloid
(CSIC; Blutal, Dainippon Pharmaceutical Co.,
Osaka, Japan) as a magnetic resonance (MR)
contrast agent to detect hepatocellular carci-
noma (HCC) (Kato et al., 1993; Kamba et al.,
1994).  Intravenous CSIC is rapidly taken up
mainly into the reticuloendothelial cells, and
consequently it reduces the signal intensity of
the liver because of a T2-shortening effect
(Kato et al., 1993).  CSIC enhances the contrast
between liver parenchyma and HCC, where the
reticuloendothelial function is impaired or
absent in the latter (Kato et al., 1993; Kamba et
al., 1994; Suto et al., 1993).  This improves the
detection of hepatocellular carcinoma (HCC)
(Kato et al., 1993; Kamba et al., 1994).  A cor-
relation has been found between the enhance-
ment of tumor-liver contrast after CSIC admin-
istration and the histologic grade of HCC (Suto
et al., 1995; Kamba et al., 1996).
On the other hand, computed tomography
during arterial portography (CTAP) and CT
arteriography are usually used to evaluate the
histologic grade of HCC from the hemodynam-
ic aspect (Matsui et al., 1991; Takayasu et al.,
1995).  In this study, we compared CSIC-
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with a 2-mm gap.  The field of view was 370
mm, and the matrix was 160 × 256.  MR images
were taken before and 1 h after intravenous
injection of 23.6 µmolFe/kg body weight of
CSIC.  All patients gave written consent to
participate in this MR study.
Regions of interest were selected to measure
the signal intensity of the lesion and surround-
ing hepatic parenchyma.  The SD of the back-
ground noise was measured from a region out-
side the body along the phase-encoding direc-
tion.  The contrast-to-noise ratio (C/N) was
calculated by dividing the difference in signal
intensity between the lesion and liver by the SD
of the background noise.  The enhancement
index was calculated by subtracting the pre-
contrast C/N from the postcontrast C/N.
CTAP and CT arteriography were perform-
ed with a Vertex 3000 (Yokogawa Medical
Systems, Tokyo, Japan) or a Somatom Plus-S
(Siemens).  Fifteen or seventeen sequential
images of the entire liver were taken with the
Vertex 3000 scanner in two or three repeat
series of five to eight contiguous scans with a
10-mm slice thickness and 10-mm table incre-
ments (scan time: 1.8 s/section).  For CTAP,
100 mL of nonionic contrast material [iohexol
(Omnipaque; Daiichi Pharmaceutical, Tokyo)
or iopamidol (Iopamiron; Nihon Schering,
Osaka), 300 mgI/mL] was injected at a rate of
1.0 to 1.3 mL/s via a catheter placed in the supe-
rior mesenteric artery.  Scanning began 25 to 30
s after starting injection.  For CT arteriography,
enhanced MR imaging with CTAP and CT
arteriography to confirm the usefulness of
CSIC-enhanced MR imaging as a noninvasive
method for evaluating the histologic grade of
HCC.
Subjects and Methods
CSIC is a stable iron colloid preparation with a
trivalent iron ion (Okuhata, 1992).  It is used in
clinical practice in Japan for treatment of iron
deficiency anemia, and its safety has already
been established (Kato et al., 1993).  It is a
paramagnetic substance with a mean molecular
weight of 75,000 (Okuhata, 1992).  The particle
size of this substance is more than 100 nm in
water (Okuhata, 1992).  Its T1 and T2 relax-
ivities are 0.44 and 2.3 s–1•mM–1, respectively,
as measured with a 1.5 T MR spectrometer at
22˚C (Okuhata, 1992).
From January 1991 to June 1994, 26 pa-
tients (17 men and 9 women, mean age:  58.7
years) with HCC underwent surgery after
CSIC-enhanced MR imaging, CTAP and CT
arteriography.  Pathological examination dis-
closed 34 HCCs in the resected specimens.
CSIC-enhanced MR imaging revealed 31
HCCs, of which 5 were well-differentiated, 6
well- to moderately-differentiated, and 20
moderately- or poorly-differentiated HCC.  The
mean diameter was 1.42 cm (range: 1.0–2.0 cm)
for the well-differentiated HCCs, 1.57 cm
(range: 1.2–2.5 cm) for the well- to
moderately-differentiated HCCs, and
4.16 cm (range: 0.9–12.0 cm) for the
moderately- or poorly-differentiated
HCCs.  For this study, the moderately-
or poorly-differentiated HCCs of 3 cm
or less in diameter (10 nodules, range:
0.9–3.0 cm, mean: 1.95 cm) were selected
to match the first two groups in size.
All patients were examined with a
Magnetom H15 system with a body coil
operating at 1.5 T (Siemens, Erlangen,
Germany).  Spin echo T2-weighted
images (repetition time/echo time
2,000/90 ms, 2 signal excitations) were
taken.  The slice thickness was 10 mm
Fig. 1.  Relationship between the findings of CTAP and the
enhancement index.  iso, isoattenuating; hypo, hypoattenu-
ating; E, well-differentiated HCC; C, well- to moderately-
differentiated HCC; F, moderately- or poorly-differentiated
HCC.
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nonionic contrast material (iohexol, 140 mgI/
mL) was injected at a rate of 1.2 to 1.5 mL/s dur-
ing scanning via a catheter placed in the com-
mon hepatic or replaced right hepatic artery.
Spiral volumetric scan (Kalender et al., 1990)
of the whole liver was done by a Somatom Plus-
S scanner during a single breathhold (up to 32 s)
with a 5-mm slice thickness and table move-
ment of 5 mm/s (scan time: 1 s/section).  For
CTAP, nonionic contrast material (iohexol, 140
mgI/mL) was injected at a rate of 3 mL/s via a
catheter placed in the superior mesenteric ar-
tery.  Scanning began 30 s after starting injec-
tion.  For CT arteriography, nonionic contrast
material (iohexol, 140 mgI/mL) was injected at
a rate of 1.2 to 1.5 mL/s during scanning via a
catheter placed in the common hepatic or
replaced right hepatic artery.
On CTAP, lesions with attenuation less than
the surrounding hepatic parenchyma were
classified into two categories: “defect” lesions
whose attenuation was less than that of the
hepatic portion of the inferior vena cava, and
“hypoattenuating” lesions whose attenuation
was equal to or greater than that of the hepatic
portion of the inferior vena cava.  Lesions with
attenuation equal to that of the surrounding
hepatic parenchyma were described as “iso-
attenuating.”
The enhancement patterns of lesions seen on
CT arteriography were classified into three
categories according to their attenuation rela-
tive to that of the surrounding hepatic paren-
chyma; hyperattenuating, isoattenuating and
hypoattenuating.
The histologic grade of HCC was assessed
according to the criteria of the Third Edition of
the General Rules for the Clinical and Patho-
logical Study of Primary Liver Cancer by the
Liver Cancer Study Group of Japan (The Liver
Cancer Study Group of Japan, 1992).
Correlations between the enhancement in-
dex and the degree of enhancement on CTAP or
CT arteriography, and between the enhance-
ment index and the histologic grade were ana-
lyzed by Spearman’s rank order test.  The level
of statistical significance was set at P < 0.05.
Results
The relationship between the findings of CSIC-
enhanced MR imaging and those of CTAP is
summarized in Fig. 1.  Seventeen HCCs (nine
moderately- or poorly-differentiated, six well-
to moderately-differentiated, and two well-
differentiated) showed defects on CTAP.  The
mean enhancement index was 2.98.  Sixteen le-
sions were positive for the enhancement index,
whereas one well- to moderately-differentiated
HCC was negative.  Three HCCs (one moder-
ately- or poorly-differentiated, and two well-
differentiated) were hypoattenuating on CTAP.
The mean enhancement index was 0.60.  Two
well-differentiated HCCs were positive for the
enhancement index, whereas one moderately-
or poorly-differentiated HCC was nega-
tive.  One well-differentiated HCC was
isoattenuating on CTAP, but it was nega-
tive for the enhancement index.  A statis-
tically significant correlation was found
between the enhancement index and
portal blood supply demonstrated by
CTAP (rS = 0.575, n = 21, P < 0.01).
The relationship between the findings
of CSIC-enhanced MR imaging and those
of CT arteriography is summarized in Fig.
2.  Fourteen HCCs (eight moderately- or
poorly-differentiated, four well- to
moderately-differentiated, and two well-
differentiated) were hyperattenuating on
CT arteriography.  The mean enhance-
Fig. 2.   Relationship between the findings of CT
arteriography and the enhancement index.   hypo, hypo-
attenuating; iso, isoattenuating; hyper, hyperattenuating; E,
well-differentiated HCC; C, well-  to moderately-differenti-
ated HCC; F, moderately- or poorly-differentiated HCC.
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Fig. 3.  A 48-year-old man with HCC.  A:  The precontrast T1-weighted image reveals a hyperintense nodule
(arrow) with a central isointense component (arrowhead).  B:  The precontrast T2-weighted image shows a
central hyperintense component (arrowhead) within a peripheral isointense area.  C:  The central component
is enhanced on the CSIC-enhanced T2-weighted image (arrowhead), whereas the peripheral component is
slightly hypointense in comparison with the surrounding liver (arrow).  D:  CTAP reveals a portal perfusion
defect corresponding to the central component (arrowhead).  The peripheral component is isoattenuating.  E:
CT-arteriography shows a central hyperattenuating area (arrowhead) and a peripheral hypoattenuating area
(arrow).  F (p. 121):  A photomicrograph of the resected specimen shows a well-differentiated HCC (right
half) and a moderately-differentiated HCC (left half).  Hematoxylin and eosin stain,  ¥ 130.  (Figures are
reprinted from Kamba et al., 1996)
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Table 1.  Relationship between the histologic grade of
HCC and the enhancement index
                         HCC                                         Enhancement
                                                                                    index
Well-differentiated [  5] 1.68 ± 2.53
Well- to moderately-differentiated [  6] 2.28 ± 2.77
Moderately- or poorly-differentiated [10] 2.82 ± 2.19
Mean ± SD.
[  ], number of lesions.
Iron colloid-enhanced MR imaging of HCC
121
ment index was 3.30.  All the lesions were posi-
tive for the enhancement index.  Six HCCs (two
moderately- or poorly-differentiated, two well-
to moderately-differentiated, and two well-
differentiated) were isoattenuating on CT arte-
riography.  One well- to moderately-differenti-
ated, and one moderately- or poorly-differenti-
ated HCC were negative for the enhancement
index.  The mean enhancement index was 1.04.
One well-differentiated HCC was hypoattenu-
ating on CT arteriography.  The lesion was
negative for the enhancement index.  A statis-
tically significant correlation was found be-
tween the enhancement index and arterial blood
supply demonstrated by CT arteriography (rS =
0.577, n = 21, P < 0.01).
Though the enhancement index tended to
increase as the grade of malignancy increased,
no statistically significant correlation was
found.  Considerable overlap in the enhance-
ment index was observed in the three histologic
grades (Table 1).
Representative case
A patient with HCC exhibiting a concentric
structure of different histologic grades under-
went surgery after CSIC-enhanced MR imag-
ing, CTAP and CT arteriography (Fig. 3).  The
central component (moderately-differentiated
HCC) was enhanced in comparison with the
surrounding liver after CSIC injection.  The pe-
ripheral component (well-differentiated HCC)
was not enhanced.  CTAP showed a portal
perfusion defect corresponding to the central
component.  The peripheral component was
isoattenuating.  CT-arteriography showed a
central hyperattenuating area and a peripheral
hypoattenuating area.
Discussion
The reticuloendothelial function in HCC differs
according to the degree of differentiation.  The
number of reticuloendothelial cells in HCC has
been reported to be lower in the less differenti-
ated HCC (Sugihara et al., 1990; Tanaka et al.,
1996).  In this study, though the enhancement
index tended to increase as the grade of malig-
nancy increased, no statistical significance was
verified because of a considerable overlap.  We
previously reported a correlation between the
enhancement of tumor-liver contrast after CSIC
administration and the histologic grade of HCC
(Suto et al., 1995).  In the present study, the
mean diameter of the moderately- or poorly-
differentiated HCCs was small in comparison
F
Legends to
Fig. 3F: p. 120
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with the previous study.   The disagreement
between the two studies is at least partially re-
lated to partial volume effects due to the respi-
ratory movements during image acquisition
(Butts et al., 1995).  Fast T2-weighted imaging
as currently offered on new scanners (Rydberg
et al., 1995) can overcome this problem and one
can expect that in reality the correlation be-
tween CSIC uptake and the degree of differ-
entiation must be better than the correlation
found in this study.
Three of the 21 HCCs were negative for the
enhancement index.  Such lesions may be indis-
tinguishable from adenomatous hyperplasia,
which has negative contrast enhancement be-
cause of the presence of reticuloendothelial
cells (Suto et al., 1993).  The number of Kupffer
cells in 20 to 25% of moderately- or poorly-
differentiated HCCs is equal to that in non-
cancerous tissue (Tanaka et al,. 1996).  The de-
crease in reticuloendothelial function demon-
strated by CSIC-enhanced MR imaging indi-
cates merely one aspect of differentiation of
HCC.  It seems difficult to assess the histologic
grade of HCC precisely by the enhancement
index alone.  The additional use of precontrast
signal intensity and morphologic features (e.g.,
capsule and mosaic pattern) must also be taken
into consideration (Kadoya et al., 1992).
The hemodynamic findings on CTAP and
CT arteriography were reported to be correlated
with the histologic grade of HCCs.  The intra-
nodular portal blood flow tends to decrease as
the grade of malignancy increases (Matsui et
al., 1991).  The intranodular arterial and portal
blood supplies have been reported to be recip-
rocal (Matsui et al., 1991).  The intermediate
lesions ranging from adenomatous hyperplasia
to well-differentiated HCCs tend to have
progressively less intranodular portal blood
supply as the grade of malignancy increases
(Matsui et al., 1991).  Takayasu and colleagues,
however, recently reported that the relationship
between the hemodynamic characteristics and
the degree of dedifferentiation of HCC could
not be verified in well-differentiated HCCs
(Takayasu et al., 1995).
The enhancement index correlated with the
intranodular blood supply on both CTAP and
CT arteriography rather than the histologic
grade.  The CT findings may be biased as well
because of partial volume averaging.  The loss
of contrast in small lesions may be the reason
why the enhancement index correlated with the
findings of CTAP and CT arteriography rather
than the histologic grade.
In contrast to CTAP and CT arteriography,
CSIC-enhanced MR imaging is a noninvasive
procedure.  In patients with marked portosys-
temic shunt and/or laminal flow of contrast
material, we found difficulty in assessing the
intranodular portal blood supply.  The hemo-
dynamic evaluation of lesions within the
wedge-shaped portal flow defect or arterio-
portal shunt was difficult.  CSIC-enhanced MR
imaging was unaffected by portal flow abnor-
malities (Kamba et al., 1994).  Spin echo imag-
ing, which we have used, is inferior to CTAP
and CT arteriography in detecting small lesions
less than 1 cm in diameter because of its lower
spacial resolution (Kamba et al., 1994).  High
resolution imaging by fast T2-weighted spin
echo sequences (Semelka et al., 1993) can
overcome this problem.
CSIC-enhanced MR imaging allowed non-
invasive evaluation of the intranodular reticulo-
endothelial function.  The findings of CSIC-
enhanced MR imaging correlated with the
hemodynamic findings on CTAP and CT arte-
riography.  We consider this procedure as a sup-
plementary method for evaluation of the histol-
ogic grade of HCC prior to performing invasive
procedures such as angiography and biopsy.
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